Home / Lanreotide / Norway
NO ATC H01CB03 · updated 2 Nov 2026
Lanreotide shortage in Norway
Is there a Lanreotide shortage in Norway?
Yes. As of 2 Nov 2026, 1 Lanreotide product is reported short in Norway, the first since 10 Dec 2025. The company estimate for the return is 31 Dec 2026. Main reason: quality problem or recall.
Also short in Germany, Italy, Spain, Austria, Australia. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Myrelez 60 mg injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 0,5 ml ferdigfylt sprøyte | Amdipharm Limited | 10 Dec 2025 | 31 Dec 2026 | Quality problem or recall Kvalitetsproblemer |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).